dopamine

depression insulin dopamine Dr Jonathan Haverkampf

Can Insulin Affect Depression by Affecting Dopamine and Reward Processing in the Brain?

Leave a Comment / Depression News, Depression Research, Depression Resources, News /

Publication date: June 2023Source: Neuroscience & Biobehavioral Reviews, Volume 149Author(s): Judith Gruber, Ruth Hanssen, Mishal Qubad, Aicha Bouzouina, Vivi Schack, Hannah Sochor, Carmen Schiweck, Mareike Aichholzer, Silke Matura, David A. Slattery, Yurdaguel Zopf, Stephanie L. Borgland, Andreas Reif, Sharmili Edwin Thanarajah

Can Insulin Affect Depression by Affecting Dopamine and Reward Processing in the Brain? Read More »

Neurotransmitters

Leave a Comment / neurotransmitter /

Neurotransmitters play an important role in transmitting information between neurons across the synaptic cleft. Various regions and pathways in the brain use different patterns of neurotransmitters and different receptor subclasses, which helps to identify the role specific neurotransmitters play in various psychiatric conditions in neuroimaging studies and can also make medication more specific. Neurotransmitters are

Neurotransmitters Read More »

Serotonin, Norepinephrine, Dopamine – Combining Medication against Depression

Leave a Comment / Uncategorized /

Serotonin, Norepinephrin, Dopamine – Combining Medication against Depression Christian Jonathan Haverkampf, M.D. A monotherapy or a combination of antidepressants that affect all three monoamines serotonin, dopamine and norepinephrine together have led to some positive results in cases of treatment-resistant depression, while some promising substances that could be used as monotherapy are still in the early

Serotonin, Norepinephrine, Dopamine – Combining Medication against Depression Read More »

Psychopharmacological Frontiers (1)

Leave a Comment / antidepressants, antipsychotics, anxiety, depression, future, medication, psychiatric medication, psychiatry, psychosis, schizophrenia, treatment /

Psychopharmacological Frontiers Christian Jonathan Haverkampf, M.D. New developments in psychopharmacology have driven much of the progress over the last decades. This article discusses new developments in the area of antidepressants and antipsychotics. Keywords: depression, SSRI, SNRI, ketamine, glutamate antagonist, NMDA, scopolamine, magnesium, glutamine, CP-AMPA, serotonin, norepinephrine, dopamine, antidepressants, major depressive disorder, medication, treatment psychiatry Table

Psychopharmacological Frontiers (1) Read More »